Gritstone Downgraded by Jones, B. Riley Over Cancer Vaccine Data
A Quick Look at Today's Ratings for Gritstone Bio(GRTS.US), With a Forecast Between $1 to $1
Gritstone Bio Cut to Market Perform From Market Outperform by JMP Securities
Gritstone Bio Analyst Ratings
JMP Securities Maintains Gritstone Bio(GRTS.US) With Hold Rating
JMP Securities Downgrades Gritstone Bio(GRTS.US) to Hold Rating
JMP Securities Maintains Gritstone Bio(GRTS.US) With Buy Rating, Maintains Target Price $5
Gritstone Bio Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Gritstone Bio, Maintains $4 Price Target
H.C. Wainwright Maintains Gritstone Bio(GRTS.US) With Buy Rating, Maintains Target Price $4
JMP Securities Maintains Gritstone Bio(GRTS.US) With Buy Rating, Maintains Target Price $5
TD Cowen Maintains Gritstone Bio(GRTS.US) With Buy Rating
Gritstone Bio Price Target Maintained With a $5.00/Share by JMP Securities
Gritstone Bio Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Gritstone Bio, Maintains $4 Price Target
H.C. Wainwright Maintains Gritstone Bio(GRTS.US) With Buy Rating, Maintains Target Price $4
JMP Securities Maintains Gritstone Bio(GRTS.US) With Buy Rating, Maintains Target Price $5
Gritstone Bio Analyst Ratings
JMP Securities Reiterates Market Outperform on Gritstone Bio, Maintains $5 Price Target
Gritstone Bio Analyst Ratings